“Biotech is not another app. This is not an e-commerce play that may go for a year or two and die out. These are things that are actually going to affect our lives, for all of us.” — Sean O’Sullivan
Is purpose increasingly shaping scientific and tech development? Is impact investing part of the society trend of realigning business priorities? How will this shape the selective pressure of science investment? Join our synthetic biology investor panel in exploring the rapidly evolving landscape of investing in things that are truly important.